This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for Somavert® (pegvisomant) Great Britain (GB) and Northern Ireland (NI)​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Somavert (pegvisomant) 10 mg powder and solvent for solution for injection - PI for GB
  • Somavert (pegvisomant) 15mg powder and solvent for solution for injection - PI for GB
  • Somavert (pegvisomant) 20mg powder and solvent for solution for injection - PI for GB
  • Somavert (pegvisomant) 25mg powder and solvent for solution for injection - PI for GB
  • Somavert (pegvisomant) 30mg powder and solvent for solution for injection - PI for GB

Northern Ireland

  • Somavert (pegvisomant) 10mg, 15mg, 20mg, 25mg and 30mg powder and solvent for solution for injection - PI for NI

Somavert (pegvisomant) 10 mg powder and solvent for solution for injection - PI for GB

Somavert (pegvisomant) 15mg powder and solvent for solution for injection - PI for GB

Somavert (pegvisomant) 20mg powder and solvent for solution for injection - PI for GB

Somavert (pegvisomant) 25mg powder and solvent for solution for injection - PI for GB

Somavert (pegvisomant) 30mg powder and solvent for solution for injection - PI for GB

Somavert (pegvisomant) 10mg, 15mg, 20mg, 25mg and 30mg powder and solvent for solution for injection - PI for NI

PP-SOM-GBR-1077 December 2021